Full Press Release Details
Genetics' Board of Directors Appoints B.G. Susan Robinson, President and CEO, as
H. Stewart Parker Resigns from the Company's Board of Directors -
Wash., November 17, 2008-
Targeted Genetics Corporation (NASDAQ:TGEN) today announced that its Board
Directors appointed B.G. Susan Robinson, President and Chief Executive Officer,
as a member of the Board of Directors effective November 14, 2008. Separately,
the Board accepted the resignation of H. Stewart Parker as a Director effective
previously announced on November 10, 2008, the Board of Directors appointed
Robinson as president and chief executive officer of the Company and Ms. Parker
resigned from her position as the president and chief executive officer of
Targeted Genetics, both effective November 6, 2008. Ms. Parker began her service
as a director of Targeted Genetics in 1989.
Targeted Genetics Corporation
Genetics Corporation is a biotechnology company committed to the development
innovative, targeted molecular therapies for the prevention and treatment of
acquired and inherited diseases with significant unmet medical need. Targeted
Genetics' proprietary Adeno-Associated Virus (AAV) technology platform allows
to deliver genes that encode proteins to increase gene function or RNAi to
decrease or silence gene function. Targeted Genetics' product development
efforts target inflammatory arthritis, AIDS prophylaxis, congestive heart
failure, Huntington's disease and Leber's congenital amaurosis. To learn more
about Targeted Genetics, visit Targeted Genetics' website at
Harbor Statement under the Private Securities Litigation Reform Act of
release contains forward-looking statements regarding the Company's liquidity
and financial resources, its ability to fund ongoing and future operations
its business strategy and product development, including statements regarding
the Company's ability to extend its cash horizon, advance its platform and
product pipeline and create value from its product candidates and other
statements about the Company's plans, objectives, intentions and expectations.
These statements involve current expectations, forecasts of future events and
other statements that are not historical facts. Inaccurate assumptions and
and unknown risks and uncertainties can affect the accuracy of forward-looking
statements. Factors that could affect actual future events or results include,
but are not limited to, the
risk that the Company will run out of cash earlier than expected, the risk
the Company will not be able to raise capital or secure other financial
resources in the near term, the risk that the Company's research and development
programs are not successful or are delayed or terminated, the risk that payments
anticipated by the Company under product development collaborations and
contracts are not earned or received when expected or at all, and the risk
the Company will not be able to maintain its listing on the NASDAQ Capital
well as other risk factors described in its filings with the Securities and
Exchange Commission (SEC), including in "Item 1A. Risk Factors" in the Company's
most recent quarterly report on Form 10-Q for the quarter ended September 30,
2008 filed with the SEC. You should not rely unduly on these forward-looking
statements, which apply only as of the date of this release. The Company
undertakes no duty to publicly announce or report revisions to these statements
as new information becomes available that may change the Company's